Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion
Journal of Hematopathology · 22.05.2026 · 19 (1)
DOI: 10.1007/s12308-026-00702-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Hematopathology, online erschienen am 22.05.2026. Verfasst von James R Cook und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Translocation, Genetic, Oncogene Proteins, Fusion, Chromosomes, Human, Pair 5. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (M/LN-eo-TK) are diverse, with most cases showing a combination of lymphoblastic leukemia/lymphoma and myeloproliferative features. Various tyrosine kinase fusion genes have been identified, including FLT3 fusions. RNA based next generation sequencing studies offer an effective approach to detect such pathogenic fusion genes, including the novel SSBP2::FLT3 fusion described here. Timely identification of this fusion gene led to targeted management of our patient, who achieved complete resolution of his FDG-avid lymphadenopathy only after the addition of gilteritinib. Two years after successful bone marrow transplant, the patient remains in complete remission. Clinicians and pathologists should have a low index of suspicion for a M/LN-eo-TK when evaluating patients with and without unexplained eosinophilia in the context of extramedullary lymphoid or myeloid disease or unusual myeloproliferative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.
- Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.
- Department of Pathology and Laboratory Medicine, Diagnostics Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA. owczara@ccf.org.
Zitieren
APA
Cook, J. R., Astbury, C., Bosler, D. S., Molina, J. C., Rogers, H. J., Sobecks, R. M., & Owczarczyk, A. B. (2026). Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion. Journal of Hematopathology, 19(1). https://doi.org/10.1007/s12308-026-00702-9
Vancouver
Cook JR, Astbury C, Bosler DS, Molina JC, Rogers HJ, Sobecks RM, et al. Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion. Journal of Hematopathology. 2026;19(1). doi:10.1007/s12308-026-00702-9
BibTeX
@article{Cook2026,
author = {Cook, James R and Astbury, Caroline and Bosler, David S and Molina, John C and Rogers, Heesun J and Sobecks, Ronald M and Owczarczyk, Anna B},
title = {Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion},
journal = {Journal of Hematopathology},
year = {2026},
volume = {19},
number = {1},
doi = {10.1007/s12308-026-00702-9}
}
EUVIMED